Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy

NCT04302454 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04302454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04302454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 19, 2020
Completion date
December 1, 2027
Enrollment
280 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer